Dosimetry-based high-activity therapy with 131I-metaiodobenzylguanidine (131I-mIBG) and topotecan for the treatment of high-risk refractory neuroblastoma

被引：0
|
作者：
Jose Genolla
Trinidad Rodriguez
Pablo Minguez
Ricardo Lopez-Almaraz
Veronica Llorens
Aizpea Echebarria
机构：
[1] Cruces University Hospital,Department of Nuclear Medicine
[2] Cruces University Hospital,Department of Medical Physics and Radiation Protection
[3] Cruces University Hospital,Department of Pediatric Oncology and Hematology
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2019年 / 46卷
关键词：
High-risk neuroblastoma; I-mIBG therapy; Topotecan; Dosimetry;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1567 / 1575
页数：8
相关论文
共 50 条
  • [21] High-dose 131I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan
    Kayano, Daiki
    Wakabayashi, Hiroshi
    Nakajima, Kenichi
    Kuroda, Rie
    Watanabe, Satoru
    Inaki, Anri
    Toratani, Ayane
    Akatani, Norihito
    Yamase, Takafumi
    Kunita, Yuji
    Hiromasa, Tomo
    Takata, Aki
    Mori, Hiroshi
    Saito, Shintaro
    Araki, Raita
    Taki, Junichi
    Kinuya, Seigo
    ANNALS OF NUCLEAR MEDICINE, 2020, 34 (06) : 397 - 406
  • [22] Dosimetry for therapeutic treatment of neuroblastoma by 131I-mIBG
    Sudbrock, F.
    Eschner, W.
    Schmidt, M.
    Simon, T.
    Hero, B.
    Schicha, H.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2006, 45 (06): : 254 - 261
  • [23] Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
    Maric, Ines
    Weber, Manuel
    Prochnow, Andre
    Schmitz, Jochen
    Unger, Nicole
    Schaarschmidt, Benedikt M.
    Poeppel, Thorsten D.
    Rischpler, Christoph
    Bockisch, Andreas
    Herrmann, Ken
    Jentzen, Walter
    Fendler, Wolfgang P.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (06) : 885 - 891
  • [24] Personalized dosimetry for a deeper understanding of metastatic response to high activity 131I-mIBG therapy in high risk relapsed refractory neuroblastoma
    Cassano, Bartolomeo
    Pizzoferro, Milena
    Valeri, Silvio
    Polito, Claudia
    Donatiello, Salvatore
    Altini, Claudio
    Villani, Maria Felicia
    Serra, Annalisa
    Castellano, Aurora
    Garganese, Maria Carmen
    Cannata, Vittorio
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (02) : 1299 - 1310
  • [25] Malignant pheochromocytomas and paragangliomas -: A phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG)
    Fitzgerald, Paul A.
    Goldsby, Robert E.
    Huberty, John P.
    Price, David C.
    Hawkins, Randall A.
    Veatch, Janet J.
    Dela Cruz, Filemon
    Jahan, Thierry M.
    Linker, Charles A.
    Damon, Lloyd
    Matthay, Katherine K.
    PHEOCHROMOCYTOMA, 2006, 1073 : 465 - 490
  • [26] Tandem High-Dose 131I-MIBG Therapy For Paediatric Patients With Relapsed-Refractory High Risk Neuroblastoma: A Dosimetry Based Treatment
    Altini, C.
    Villani, M.
    Cassano, B.
    Pizzoferro, M.
    Serra, A.
    Castellano, A.
    Cannata, V.
    Garganese, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S689 - S689
  • [27] Effectiveness of high-dose 131I-MIBG as consolidation therapy for the patients with high-risk neuroblastoma
    Inaki, A.
    Kuroda, R.
    Wakabayashi, H.
    Akatani, N.
    Yamase, T.
    Kunita, Y.
    Watanabe, S.
    Hiromasa, T.
    Mori, H.
    Saito, S.
    Ikawa, Y.
    Kayano, D.
    Kinuya, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S279 - S279
  • [28] TREATMENT OF ADVANCED NEUROBLASTOMA WITH 131I-METAIODOBENZYLGUANIDINE
    CLAUDIANI, F
    GARAVENTA, A
    BERTOLAZZI, L
    CABRIA, M
    VILLAVECCHIA, GP
    STIMAMIGLIO, P
    BIASSONI, L
    LANINO, E
    DEBERNARDI, B
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1992, 19 (08): : 708 - 708
  • [29] The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
    Reineke A. Schoot
    Gitta Bleeker
    Huib N. Caron
    Berthe L. van Eck
    Hugo A. Heij
    Jan de Kraker
    Godelieve A. Tytgat
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1516 - 1522
  • [30] The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
    Schoot, Reineke A.
    Bleeker, Gitta
    Caron, Huib N.
    van Eck, Berthe L.
    Heij, Hugo A.
    de Kraker, Jan
    Tytgat, Godelieve A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (10) : 1516 - 1522
12345